source
- Migraine biotech Vedana Therapeutics raises $46 million Series A to advance preclinical pipelineVedana Therapeutics, a new biotech focused on migraine, has announced its emergence from stealth mode after securing a Series A financing round. The company raised $46 million from investors, whic…
- FTC and Four State Attorneys General Sue Transgender Health Group Over Alleged Misleading ClaimsThe Federal Trade Commission, together with attorneys general from Alaska, Iowa, Nebraska and Texas, filed a lawsuit on Wednesday in a Texas federal court against the World Professional Association…